Serous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation.

Source:http://linkedlifedata.com/resource/pubmed/id/18248390

Download in:

View as

General Info

PMID
18248390